triacetin has been researched along with ACY2 Deficiency in 2 studies
Triacetin: A triglyceride that is used as an antifungal agent.
triacetin : A triglyceride obtained by acetylation of the three hydroxy groups of glycerol. It has fungistatic properties (based on release of acetic acid) and has been used in the topical treatment of minor dermatophyte infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madhavarao, CN | 1 |
| Arun, P | 1 |
| Anikster, Y | 2 |
| Mog, SR | 1 |
| Staretz-Chacham, O | 2 |
| Moffett, JR | 1 |
| Grunberg, NE | 1 |
| Gahl, WA | 2 |
| Namboodiri, AMA | 1 |
| Segel, R | 1 |
| Zevin, S | 1 |
| Steinberg, A | 1 |
| Fisher, D | 1 |
| Zimran, A | 1 |
| Altarescu, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Oral Glyceryl Triacetate (GTA) in Newborns With Canavan[NCT00724802] | 1 participants (Anticipated) | Interventional | 2008-03-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for triacetin and ACY2 Deficiency
| Article | Year |
|---|---|
Glyceryl triacetate for Canavan disease: a low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model.
Topics: Acetates; Administration, Oral; Animals; Animals, Newborn; Canavan Disease; Dietary Supplements; Dis | 2009 |
A safety trial of high dose glyceryl triacetate for Canavan disease.
Topics: Brain; Canavan Disease; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neuroprotective Ag | 2011 |